Form 4: UnitedHealth Group Director Charles D. Baker Reports Acquisition of Common Stock
SEC Form 4 Filing
Director Charles D. Baker reports acquiring 4 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.
Summary
- Charles D. Baker, a director at UnitedHealth Group, reported a transaction on March 18, 2025.
- He acquired 4 shares of common stock.
- The acquisition was due to dividend equivalents paid on vested deferred stock units.
- The price of the acquired stock was $0.
- Following the transaction, Baker's beneficially owned securities amount to 803 shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with securities regulations.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it involves a small number of shares acquired through dividend equivalents.
Key Dates
| Date | Description |
|---|---|
| 03/18/2025 | Date of transaction: Acquisition of common stock. |
| 03/20/2025 | Date of signature on the report. |
Keywords
Form 4, UnitedHealth Group, Director, Stock Acquisition, Dividend Equivalents, Charles D. Baker, UNH
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.